Exceptional review of NICE fetal monitoring recommendations

You can now review and comment on this draft addendum.

The consultation closes on 25 November 2016 at 5pm

How to comment

1. Register your organisation

Your organisation needs to be registered as a stakeholder before we can accept comments.

Not eligible? Contact the stakeholder organisation that most closely represents your interests and pass your comments to them.

2. Read the consultation documents

Documents to comment on:

• Full draft addendum
• Short version of addendum
• Full addendum appendices (except appendix G)
• Full addendum appendix G

We would particularly welcome your views on the following questions regarding the content of the recommendations:

Monitoring on admission

1. For how long and when should the fetal heart be auscultated? For example, 1 minute during or immediately after a contraction or between contractions?

Interpretation of cardiotocograph (CTG) traces

2. Which is your preferred classification of cardiotocograph (CTG) features and why? In particular, should the category currently termed ‘non-reassuring’ be termed ‘non-reassuring’ or ‘suspicious’ or something else?
3. How should CTG traces be classified overall and why?
4. In the table about the overall classification of CTG traces, should the third row (‘CTG suggests high risk of fetal acidosis’) and the fourth row (‘CTG indicates need for urgent intervention’) be combined and if so how could this be achieved?

Fetal blood sampling

5. Should there be a specific recommendation about performing fetal blood sampling in woman with pyrexia, sepsis or meconium? The Committee was aware that fetal blood sampling may give inappropriate reassurance in these cases.
6. Should pH or lactate or both together be measured in fetal blood samples, or is further research needed to determine this?

Other information about the consultation

• Developing NICE guidelines: how to get involved

3. Add your comments

• You must use this comments form
• You must declare any links with, or funding from, the tobacco industry

If you share similar views with another organisation, send a joint response.

Make sure you consider:

• The areas that will have the biggest impact on practice and be challenging to implement
• How to help users overcome challenges

Developing NICE guidelines: how to get involved suggests some other areas to comment on.

4. Email the form to us

Email: IPCHighRisk@nice.org.uk

Deadline: 25 November 2016, 5pm